Fresenius Medical Care AG & Co. KGaA (Frankfurt Stock Exchange: FME / New York Stock Exchange: FMS), the world’s largest provider of dialysis products and services, announced an agreement with Abu Dhabi Health Services Co. PJSC (SEHA) for the management of its dialysis facilities in the emirate of Abu Dhabi. SEHA is a public provider of health care services in the United Arab Emirates. Both parties announced their signing of a non-binding memorandum of understanding on the deal in September 2010. The 10-year agreement is effective as of March 27, 2011. Fresenius Medical Care will manage SEHA’s six dialysis clinics in the emirate and treat a total of approximately 600 patients. A further 260-patient dialysis facility is currently under construction. Clinic physicians and nursing staff remain employees of SEHA. Both parties have agreed not to disclose financial details of the transaction.

“This agreement enables Fresenius Medical Care to expand its presence in a key Middle Eastern market,” said Dr. Emanuele Gatti, the company’s global chief strategist and CEO for Europe, Latin America, the Middle East and Africa. “As a vertically integrated dialysis company, we are the right partner for successful, long-term cooperation to improve the quality of dialysis patients’ lives in Abu Dhabi. At the same time, the contract is an excellent basis for further growth of our company in this region.”

Saif Bader Al Qubaisi, managing director and chairman of SEHA, commented: “Our goal is to provide world-class health care services for the citizens of Abu Dhabi. We are confident that the management partnership in our medical facilities will achieve the same outstanding quality treatment provided by Fresenius Medical Care’s own dialysis clinics.”

This news is also available in <link file:2127 - download "Initiates file download">PDF</link> format.

***

Fresenius Medical Care is the world's largest integrated provider of products and services for individuals undergoing dialysis because of chronic kidney failure, a condition that affects more than 2 million individuals worldwide. Through its network of 2,757 dialysis clinics in North America, Europe, Latin America, Asia-Pacific and Africa, Fresenius Medical Care provides dialysis treatment to 214,648 patients around the globe. Fresenius Medical Care also is the world's leading provider of dialysis products such as hemodialysis machines, dialyzers and related disposable products. Fresenius Medical Care is listed on the Frankfurt Stock Exchange (FME, FME3) and the New York Stock Exchange (FMS, FMS/P).

About the SEHA HealthSystem and Abu Dhabi Health Services Co. PJSC (SEHA)

Abu Dhabi Health Services Co. PJSC is an independent, public joint-stock company wholly owned by the government of Abu Dhabi and founded to manage the curative activities of the emirate’s public health care system. The company owns and operates all the public hospitals and clinics in the emirate of Abu Dhabi which together make up the SEHA HealthSystem. Its holdings include 12 hospitals with 2,644 beds, and more than 60 ambulatory and primary health care clinics, including comprehensive laboratory and modern diagnostic facilities. SEHA is one of the largest integrated health care providers in the Middle East, employing over 17,000 doctors, nurses, ancillary care and administrative personnel. SEHA means “health” in Arabic. Visit the SEHA website at www.seha.ae.

Legal Disclaimer:
This release contains forward-looking statements that are subject to various risks and uncertainties. Actual results could differ materially from those described in these forward-looking statements due to certain factors, including changes in business, economic and competitive conditions, regulatory reforms, foreign exchange rate fluctuations, uncertainties in litigation or investigative proceedings, and the availability of financing. These and other risks and uncertainties are detailed in Fresenius Medical Care AG & Co. KGaA's reports filed with the U.S. Securities and Exchange Commission. Fresenius Medical Care AG & Co. KGaA does not undertake any responsibility to update the forward-looking statements in this release.

***